An in vitro modeling of periodontal disease points out that MF alleviates inflammatory response by inhibiting the expression of interleukin-6 (IL-6) and activation of Toll-like receptor (TLR) signaling [29]. This evidence concerns the gene IL6 and periodontal disorder.